Lv21
160 积分 2024-09-16 加入
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
1小时前
已完结
Comparative effectiveness of peroxisome proliferator–activated receptor agonists as second-line therapies for primary biliary cholangitis: A systematic review and network meta-analysis
2天前
已完结
A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in mice
1个月前
已完结
Autophagy of Kupffer cells modulates CD8 + T cell activation in primary biliary cholangitis
1个月前
已完结
Elafibranor: First Approval
1个月前
已完结
Mortality factors associated with chronic pancreatitis. Unidimensional and multidimensional analysis of a medical-surgical series of 240 patients
4个月前
已关闭
Prognosis of chronic pancreatitis: an international multicenter study. International Pancreatitis Study Group
5个月前
已关闭
Uncovering novel exosome-specific miRNA markers and potential molecular mechanisms in autoimmune pancreatitis
7个月前
已完结
The diagnostic accuracy of physical signs: practice experience compared with research evidence
7个月前
已完结
皖公网安备34019202002308
